about
Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.Study of enzyme replacement therapy for Gaucher Disease: comparative analysis of clinical and laboratory parameters at diagnosis and after two, five and ten years of treatment.Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease.
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Optimal therapy in Gaucher disease
@en
Optimal therapy in Gaucher disease
@nl
type
label
Optimal therapy in Gaucher disease
@en
Optimal therapy in Gaucher disease
@nl
prefLabel
Optimal therapy in Gaucher disease
@en
Optimal therapy in Gaucher disease
@nl
P2860
P356
P1476
Optimal therapy in Gaucher disease
@en
P2093
Ozlem Goker-Alpan
P2860
P304
P356
10.2147/TCRM.S6955
P577
2010-07-21T00:00:00Z